| __timestamp | Amphastar Pharmaceuticals, Inc. | Ascendis Pharma A/S |
|---|---|---|
| Wednesday, January 1, 2014 | 28427000 | 19698000 |
| Thursday, January 1, 2015 | 37065000 | 40528000 |
| Friday, January 1, 2016 | 41199000 | 66022000 |
| Sunday, January 1, 2017 | 43415000 | 99589000 |
| Monday, January 1, 2018 | 57564000 | 140281000 |
| Tuesday, January 1, 2019 | 68853000 | 191621000 |
| Wednesday, January 1, 2020 | 67229000 | 260904000 |
| Friday, January 1, 2021 | 60932000 | 295867000 |
| Saturday, January 1, 2022 | 74771000 | 379624000 |
| Sunday, January 1, 2023 | 73741000 | 413454000 |
| Monday, January 1, 2024 | 307004000 |
Unlocking the unknown
In the ever-evolving pharmaceutical industry, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Ascendis Pharma A/S and Amphastar Pharmaceuticals, Inc. have demonstrated contrasting approaches to R&D investment. Ascendis Pharma A/S has shown a remarkable increase in R&D expenses, growing by over 2,000% from 2014 to 2023. This Danish company has consistently prioritized innovation, with its R&D spending peaking at approximately 413 million in 2023. In contrast, Amphastar Pharmaceuticals, Inc., based in the United States, has maintained a more conservative growth in R&D spending, with a 160% increase over the same period, reaching around 74 million in 2023. This comparison highlights the diverse strategies within the pharmaceutical sector, where some companies aggressively invest in future breakthroughs, while others take a more measured approach.
Comparing Innovation Spending: Incyte Corporation and Amphastar Pharmaceuticals, Inc.
Comparing Innovation Spending: Sarepta Therapeutics, Inc. and Amphastar Pharmaceuticals, Inc.
Ascendis Pharma A/S vs Verona Pharma plc: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Ascendis Pharma A/S and Ionis Pharmaceuticals, Inc.
Ascendis Pharma A/S vs CRISPR Therapeutics AG: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Ascendis Pharma A/S and Novavax, Inc.
Research and Development: Comparing Key Metrics for Halozyme Therapeutics, Inc. and Amphastar Pharmaceuticals, Inc.
Analyzing R&D Budgets: Opthea Limited vs Amphastar Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Bausch Health Companies Inc. and Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals, Inc. or MannKind Corporation: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Amphastar Pharmaceuticals, Inc. and Celldex Therapeutics, Inc.
R&D Insights: How Amphastar Pharmaceuticals, Inc. and Viridian Therapeutics, Inc. Allocate Funds